RNLXY · Renalytix plc
Substantial doubt about the company's ability to continue as a going concern.
“As a result of the Company's losses and its projected cash needs, as defined in the accounting literature, substantial doubt exists about the Company's ability to continue as a going concern. While subsequent to September 30, 2024, the company has successfully raised approximately $14.9 million, net of expenses, in new equity capital and restructured the existing long-term debt recorded on the balance sheet, the Company does have a history of operating losses and it has been expensive to deliver all of the milestones to commercialize the kidneyintelX.dkd test. … As such, management has concluded that there is a going concern uncertainty. The consolidated financial statements do not include any adjustments that may result from the outcome of this going concern uncertainty.”View the 10-Q filed Nov 19, 2024
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
RNLXY Latest Reported Short Interest
FINRA reported 327 RNLXY shares sold short as of the August 14, 2026 settlement date, a decrease of 38,200 shares. Days to cover was 1.00 based on FINRA's reported average daily volume.
Official FINRA short-interest data · share counts are restated for subsequent splits of this listing
Positioning score 32.8 + catalyst boost 20 (total capped at 100). This is a screening index, not a probability of a squeeze.
Method and coverage limits
Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-08-14). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.
Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.
The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.
Options positioning & squeeze sensitivity
Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.
No active listed options were found.
Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.
Assessment prepared 2026-09-07 09:36 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-09-15
Scheduled
FINRA publishes Sep 24
|
— | — | — | — |
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
| 2026-08-14 | 327 | 38,527 | -38,200 | 1.00 |
| 2026-07-31 | 38,527 | 12,666 | +25,861 | 3.72 |
| 2026-07-15 | 12,666 | 40,105 | -27,439 | 1.22 |
| 2026-06-30 | 40,105 | 23,037 | +17,068 | 4.79 |
| 2026-06-15 | 23,037 | 37,941 | -14,904 | 5.71 |
| 2026-05-29 | 37,941 | 25,191 | +12,750 | 4.26 |
| 2026-05-15 | 25,191 | 21,758 | +3,433 | 9.91 |
| 2026-04-30 | 21,758 | 19,662 | +2,096 | 7.22 |
| 2026-04-15 | 19,662 | 327 | +19,335 | 2.10 |
| 2026-03-31 | 327 | 679 | -352 | 1.00 |
| 2026-03-13 | 679 | 1,877 | -1,198 | 1.00 |
| 2026-02-27 | 1,877 | 546 | +1,331 | 1.00 |
| 2026-02-13 | 546 | 327 | +219 | 1.00 |
| 2026-01-30 | 327 | 2,056 | -1,729 | 1.00 |
| 2026-01-15 | 2,056 | 1,977 | +79 | 1.00 |
| 2025-12-15 | 5,249 | 218 | +5,031 | 1.28 |
| 2025-11-28 | 218 | 63 | +155 | 2.85 |
| 2025-11-14 | 63 | 47 | +16 | 1.00 |
| 2025-10-31 | 47 | 46 | +1 | 1.00 |
| 2025-10-15 | 46 | 47 | -1 | 1.00 |
| 2025-09-30 | 47 | 18 | +29 | 1.00 |
| 2025-09-15 | 18 | 19 | -1 | 1.00 |
Full FINRA short interest reporting calendar